356 filings
ARS
2023 FY
VRDN
Viridian Therapeutics Inc
26 Apr 24
Annual report to shareholders
8:34am
DEFA14A
VRDN
Viridian Therapeutics Inc
26 Apr 24
Additional proxy soliciting materials
8:32am
DEF 14A
VRDN
Viridian Therapeutics Inc
Definitive proxy
26 Apr 24
8:30am
8-K
VRDN
Viridian Therapeutics Inc
16 Apr 24
Entry into a Material Definitive Agreement
4:06pm
S-8
VRDN
Viridian Therapeutics Inc
28 Feb 24
Registration of securities for employees
4:10pm
8-K
zdp0o424c l64rlv3
27 Feb 24
Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
4:07pm
8-K
92lc8vzlw lwn
19 Jan 24
Entry into a Material Definitive Agreement
5:22pm
424B5
hgdfvfg5
19 Jan 24
Prospectus supplement for primary offering
4:32pm
424B5
fhargsth5201hx gwh85
17 Jan 24
Prospectus supplement for primary offering
4:04pm
8-K
p0jtqzqe6zz7ij1 w5o
8 Jan 24
Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference
8:08am
8-K
gj5z 58ny23q0zusdp
18 Dec 23
Amendments to Articles of Incorporation or Bylaws
8:15am
S-3ASR
jl6g 3h58
30 Nov 23
Automatic shelf registration
4:05pm
8-K
zjawey709m6r5m oyju
13 Nov 23
Viridian Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:06pm
8-K
fy6pwa
2 Nov 23
Departure of Directors or Certain Officers
4:31pm
8-K
dft0kja
30 Oct 23
Entry into a Material Definitive Agreement
8:35am
8-K
4dpot1ww hexbqsvbl
25 Sep 23
Departure of Directors or Certain Officers
8:00am
8-K
ixc9 cnhphby
12 Sep 23
Departure of Directors or Certain Officers
4:31pm
S-8
xhm4pzwd 2dx5
8 Aug 23
Registration of securities for employees
5:21pm